Trade Ideas September 15, 2026 07:35 AM

Buy the Dip: Coherent (COHR) Looks Poised for a Recovery from Oversold Levels

Strong datacenter demand, healthy balance sheet, and technical support make COHR a tactical long with defined risk controls.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
COHR

Coherent's exposure to AI-driven optical demand and recent earnings strength create a buy-the-dip setup after a sharp pullback. The business prints high growth, manageable leverage and an attractive risk/reward if investors buy near current levels with a disciplined stop. Valuation is rich on multiples today, but liquidity and secular tailwinds underpin a tactical long for patient traders.

Buy the Dip: Coherent (COHR) Looks Poised for a Recovery from Oversold Levels
COHR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Coherent serves AI datacenter and semiconductor markets with optical and laser components; recent revenue growth was ~33.8% YoY.
  • Balance sheet shows low leverage (debt/equity ~0.3) and healthy liquidity (current ratio 2.43), but free cash flow was negative (~-$1.02B).
  • Technical indicators show neutral-to-improving momentum (RSI ~42, MACD bullish histogram) and average daily volume ~6M supporting liquidity.
  • Trade plan: buy at $270.00, stop $240.00, target $380.00, horizon long term (180 trading days).

Hook & Thesis

Coherent (COHR) just presented a clean buy-the-dip opportunity. The shares moved lower into the $260s–$280s after a steep move from the June highs near $440; the pullback looks overdone relative to the company's continued top-line momentum. With FY momentum driven by datacenter and communications optics, a strong current ratio (2.43), low leverage (debt/equity ~0.3), and bullish technical momentum, this is a tactical long where upside to the prior highs is plausible if growth holds.

My trade thesis: buy COHR at the current price area as a disciplined rebound trade. The setup pairs growth evidence (recent quarter with revenues up 33.8% YoY and management guidance implying continued strong growth) with an entry close to a near-term technical and liquidity pocket. Risk is defined with a tight stop; upside targets assume normalization of multiples alongside continued revenue acceleration into AI-related optical demand.

What the company does and why the market should care

Coherent develops engineered materials, opto-electronic components and devices, and lasers used across Networking, Materials and Lasers segments. Practically, that means InP and compound semiconductor platforms, optical components for high-speed datacenter links, and lasers for semiconductor capital equipment and precision manufacturing. Those products sit directly in front of the AI build-out: hyperscaler capex on data-center networking and next-generation optics is the fundamental driver for Coherent's near-term revenue growth.

Why this dip matters

The recent pullback offers a chance to buy a company still producing strong growth. Coherent's last reported quarter showed adjusted EPS beating by 7.4% and revenue growing 33.8% year-over-year, with guidance pointing to sequential and annual acceleration (management implied next-quarter growth in the range of mid-to-high double digits, with one guide implying roughly 45.6% YoY revenue growth). Institutions that underreact to near-term inventory or capex concerns create the tactical opportunity.

Key fundamentals and technicals to support a long

  • Current price: $272.06. Market cap around $52.2B.
  • Earnings per share (trailing): $3.93; reported P/E in our dataset about ~68x (reflecting rapid growth but also premium multiples).
  • Liquidity and leverage: current ratio 2.43, quick ratio 1.52, debt/equity roughly 0.3. These metrics suggest manageable balance-sheet risk even while FCF is negative in the last period (~-$1.02B).
  • Trading technicals: 10/20/50 day SMAs sit above current price (SMA-50 ~ $299), RSI is neutral at ~42, and MACD histogram shows early bullish momentum. Average daily volume about 6M shares, which supports execution of a defined entry.
  • Range: 52-week high $440, 52-week low $100.63—the stock has wide volatility, which supports larger upside when growth re-rates but also increases drawdown risk.

Valuation framing

At roughly $52.2B market capitalization and an enterprise value near $54.25B, Coherent trades at premium growth multiples: price-to-earnings in the high 60s and price-to-sales roughly 7.3x. On the one hand this is expensive versus broad-market averages; on the other hand it reflects Coherent's role as a growth supplier to hyperscalers and telecom customers in a structurally expanding market for AI optics and semiconductor lasers.

Compare qualitatively rather than mechanically: Coherent commands premium multiples because its components are mission-critical for next-gen networking (800G and beyond) and it has exposure to semiconductor tools where content per tool is rising. Valuation therefore requires continued top-line outperformance to justify multiples; the trade is less a value play and more a growth-recovery directional bet with controlled downside.

Catalysts (2–5)

  • Continued datacenter uptake: incremental wins with hyperscalers and increased optical content per server would show through as stronger revenue beats in the coming quarters.
  • Order re-acceleration / backlog conversions: execution that reduces inventory concerns and demonstrates sustainable book-to-bill would be a re-rating event.
  • Capacity expansions coming online at scale: if Coherent can show roadmap confidence for increased InP and compound semiconductor output, revenue cadence could accelerate.
  • Industry consolidation or supply tightness for inputs (e.g., substrates) could lift pricing and margins across the optics supply chain.

Trade plan - actionable specifics

Entry: $270.00 (aggressive nibble at current levels; execute with size discipline).
Stop loss: $240.00 (company-level risks and technical breach below recent support).
Primary target: $380.00 (long term target reflecting partial re-rating toward the middle of the 52-week range).
Time horizon: long term (180 trading days) — allow several quarters for order cadence and revenue recognition to clear inventory and for market multiple normalization.

Practical approach: scale in with 50% of intended position at the entry price and the remainder on any additional 6–8% pullback or upon evidence of improving bookings. Take partial profits at $340 as a mid-term milestone (around 45 trading days) and trail the remainder toward $380 with a tightening stop once above $340.

Plan Item Detail
Entry $270.00
Stop Loss $240.00
Target $380.00
Horizon Long term (180 trading days)

Risks and counterarguments

This is not a low-risk trade. Below are the principal risks to monitor:

  • High valuation sensitivity - At ~68x trailing EPS and >7x sales, any slowdown in bookings or margins could trigger outsized multiple compression.
  • Negative free cash flow - The company reported negative free cash flow (about -$1.02B), which means capital intensity and inventory investments could pressure liquidity if revenues soften.
  • Inventory/capex concerns - Recent commentary flagged elevated inventory and heavy capex needs across the optics supply chain; an inventory-led destocking cycle could reduce near-term bookings and revenue recognition.
  • Competition and substrate supply - Competitors and substrate suppliers expanding capacity could compress pricing or push gross margins lower.
  • Macro or hyperscaler capex re-prioritization - Hyperscaler or telco customers could shift timelines for rollouts, slowing order flow materially for components tied to new optical generations.

Counterargument to my thesis: the market could be pricing a meaningful near-term slowdown in order flow and a necessary capital spending wave to retool capacity; if bookings weaken and management reduces guidance, multiples could still fall from current levels and make the current entry a poor timing choice.

Why I still prefer a tactical long: the balance-sheet metrics (current ratio 2.43, low leverage) reduce bankruptcy risk and give the company runway to execute through cycles. The underlying demand drivers for AI and next-gen optics remain intact; this trade is a defined-risk rebound rather than a buy-and-forget value call.

What would change my mind

I will exit or significantly trim the position if any of the following occur: a) management issues guidance materially below the current implied growth trajectory for multiple quarters; b) sequential deterioration in book-to-bill or confirmed order cancellations from hyperscaler customers; or c) a liquidity squeeze evidenced by worsening working-capital metrics and materially negative cash balances. Conversely, I would add to the position if bookings and backlog growth accelerate materially and quarterly revenue beats become the norm, which would justify moving toward prior highs.

Conclusion

Coherent is a buy-the-dip candidate for traders willing to accept rich multiples in exchange for exposure to a secular growth story tied to AI data-center and semiconductor equipment demand. The combination of robust revenue growth, sound liquidity, and early bullish technical signals supports a long with tight risk controls. Use the specified entry at $270.00, a stop at $240.00, and a long-term target of $380.00, while watching booking trends, cash flow, and margin behavior closely. This is a tactical, defined-risk trade rather than a valuation bargain—act accordingly.

Risks

  • High valuation - trailing P/E near ~68x and P/S ~7.3x leaves the stock vulnerable to downside if growth stalls.
  • Negative free cash flow and heavy capex needs could pressure liquidity and require additional investment while margins compress.
  • Inventory and order-book volatility; a destocking cycle or order delays from hyperscalers would hit near-term revenue.
  • Intense competition and capacity expansion among peers and substrate suppliers could put pressure on pricing and gross margins.

More from Trade Ideas

Texas Instruments: Earnings Rebound Still Has Room to Run — A Mid-Term Long Trade Sep 15, 2026 Bought the Dip in Credo: Aggressive Long After the Post-Earnings Flush Sep 15, 2026 Buy the Cash Flow, Not the Sell-Calls: T. Rowe Price Looks Cheap With Dividend Support Sep 15, 2026 Buy the Dip in Boston Scientific: Quality Medtech with Meaningful Upside Sep 15, 2026 B2Gold's Prepay Clearout: A Setup for a Cash-Flow Rebound Sep 15, 2026